Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
62% of U.S. adults own stocks, mostly through funds and retirement accounts. Wealthiest 1% hold half of all stocks; bottom 50% just 1%. Stock market offers roughly 10% annual returns, significant for ...
Investing in stocks, especially via ETFs and mutual funds, enables long-term wealth growth. Consider bonds for capital preservation and income as retirement approaches. Diversify investments across ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results